Drugs / 68Ga-BNOTA-PRGD2
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02511197 | May 2015 → Dec 2017 | pulmonary fibrosis | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT01801371 | Oct 2012 → Dec 2017 | glioma | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT01542073 | Feb 2012 → Dec 2017 | coronary artery disorder | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT01940926 | Feb 2012 → Nov 2017 | rheumatoid arthritis | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT01656785 | Feb 2012 → Dec 2017 | stroke disorder | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| Phase 0 | NCT01527058 | Dec 2011 → Dec 2017 | lung cancer | Peking Union Medical College Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-BNOTA-PRGD2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01656785 ↗ |
| Known as | 68Ga-NOTA-PRGD2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02511197 ↗ |
| Modality | Diagnostic / imaging agent | “diagnostic performance of 68Ga-BNOTA-PRGD2” NCT01527058 ↗ |
| Route | Intravenous | “single intravenous bolus injection” NCT01527058 ↗ |